• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因筛查:奇迹还是威胁?

Genetic screening: marvel or menace?

作者信息

Rowley P T

出版信息

Science. 1984 Jul 13;225(4658):138-44. doi: 10.1126/science.6729472.

DOI:10.1126/science.6729472
PMID:6729472
Abstract

Genetic screening is a systematic search in the population for persons of certain genotypes. The usual purpose is to detect persons who themselves or whose offspring are at risk for genetic diseases or genetically determined susceptibilities to environmental agents. Is genetic screening a marvel about to free us from the scourge of genetic disease or a menace about to invade our privacy and determine who may reproduce? There are three different types of genetic screening. Newborn screening identifies serious genetic disease at birth, permitting prompt treatment to prevent mental and physical retardation. Fetal screening and prenatal diagnosis identify genetic disease in the fetus permitting selective termination of pregnancy and the opportunity to have children free of defects detectable in utero. Carrier screening identifies individuals heterozygous for a gene for a serious recessive disease who may be at risk for affected offspring. The challenge to society is to provide (by way of cost-effective programs) expert services, including genetic counseling and follow-up, to all who may benefit, to ensure confidentiality and freedom of choice, and to avoid misunderstanding and stigmatization. It is recommended that the objective of screening programs should be to maximize the options available to families at risk rather than to reduce the incidence of genetic diseases. Whenever possible, the providers of these services should be the providers of primary health care. Urgently needed are a greater awareness of avoidable genetic diseases on the part of primary care providers and efforts to familiarize the public with the basic concepts of human genetics through the public school system.

摘要

基因筛查是在人群中对具有特定基因型的个体进行系统的搜寻。其通常目的是检测那些自身或其后代有患遗传疾病风险或对环境因素有遗传易感性的个体。基因筛查究竟是即将把我们从遗传疾病的祸害中解救出来的奇迹,还是即将侵犯我们的隐私并决定谁可以生育的威胁呢?基因筛查有三种不同类型。新生儿筛查在出生时识别严重的遗传疾病,以便及时治疗以预防智力和身体发育迟缓。胎儿筛查和产前诊断在胎儿期识别遗传疾病,从而允许选择性终止妊娠,并提供生育无子宫内可检测缺陷孩子的机会。携带者筛查识别携带严重隐性疾病基因的杂合个体,这些个体的后代可能有患病风险。社会面临的挑战是(通过具有成本效益的项目)为所有可能受益的人提供专业服务,包括遗传咨询和后续跟进,确保保密和选择自由,并避免误解和污名化。建议筛查项目的目标应该是最大化有风险家庭的选择,而不是降低遗传疾病的发病率。只要有可能,这些服务应由初级卫生保健提供者提供。迫切需要初级保健提供者更多地了解可避免的遗传疾病,并努力通过公立学校系统让公众熟悉人类遗传学的基本概念。

相似文献

1
Genetic screening: marvel or menace?基因筛查:奇迹还是威胁?
Science. 1984 Jul 13;225(4658):138-44. doi: 10.1126/science.6729472.
2
Legal implications of amniocentesis.
Univ PA Law Rev. 1974 Nov;123(1):92-156.
3
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.加拿大妇产科医师学会(SOGC)和加拿大医学遗传学会(CCMG)关于生殖遗传携带者筛查的联合意见:面向直接面向消费者检测时代所有加拿大孕产妇和生殖健康护理提供者的最新信息。
J Obstet Gynaecol Can. 2016 Aug;38(8):742-762.e3. doi: 10.1016/j.jogc.2016.06.008.
4
Ethical issues in prenatal diagnosis.产前诊断中的伦理问题。
Clin Obstet Gynecol. 1988 Jun;31(2):408-17. doi: 10.1097/00003081-198806000-00014.
5
Tay-Sachs disease: to screen or not to screen?泰-萨克斯病:筛查还是不筛查?
J Relig Health. 1976 Oct;15(4):271-81. doi: 10.1007/BF01533311.
6
Heredity insurance.遗传保险。
N Y Times Mag. 1978;30 Apr 1978.
7
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
8
Ethical and social aspects of risk predictions.风险预测的伦理与社会层面
Clin Genet. 1984 Jan;25(1):25-32. doi: 10.1111/j.1399-0004.1984.tb00458.x.
9
Public policy implications of human genetic technology: genetic screening.人类基因技术的公共政策影响:基因筛查
J Med Philos. 1982 Nov;7(4):355-74. doi: 10.1093/jmp/7.4.355.
10
Prenatal genetic carrier testing using triple disease screening.采用三联疾病筛查进行产前基因携带者检测。
JAMA. 1997 Oct 15;278(15):1268-72.

引用本文的文献

1
Informed Choice for Participation in Down Syndrome Screening: Development and Content of a Web-Based Decision Aid.参与唐氏综合征筛查的知情选择:基于网络的决策辅助工具的开发与内容
JMIR Res Protoc. 2015 Sep 21;4(3):e113. doi: 10.2196/resprot.4291.
2
Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications.为镰状细胞特质制定研究议程:基于对临床事件及其潜在影响的现有理解。
Am J Hematol. 2012 Mar;87(3):340-6. doi: 10.1002/ajh.22271. Epub 2012 Feb 3.
3
A review of biochemical and ultrasound markers in the detection of down syndrome.
检测唐氏综合征时生化及超声标志物的综述。
J Perinat Educ. 2006 Winter;15(1):19-25. doi: 10.1624/105812406X92958.
4
The "new genetics": an ethical perspective from family practice.“新遗传学”:家庭医疗的伦理视角
Can Fam Physician. 1988 Apr;34:941-4.
5
Public attitudes toward fetal diagnosis and the termination of life.公众对胎儿诊断及终止妊娠的态度。
Soc Indic Res. 1993;28:117-36. doi: 10.1007/BF01079654.
6
Down syndrome: effects of demographic factors and prenatal diagnosis on the future livebirth prevalence.唐氏综合征:人口统计学因素及产前诊断对未来活产患病率的影响
Hum Genet. 1993 Sep;92(2):163-8. doi: 10.1007/BF00219685.
7
Molecular genetics of common diseases.常见疾病的分子遗传学
Br Med J (Clin Res Ed). 1987 Sep 26;295(6601):769-71. doi: 10.1136/bmj.295.6601.769.
8
Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model.血红蛋白病的产前筛查。III. 健康信念模型的适用性。
Am J Hum Genet. 1991 Mar;48(3):452-9.
9
Prenatal screening for hemoglobinopathies. I. A prospective regional trial.血红蛋白病的产前筛查。I. 一项前瞻性区域试验。
Am J Hum Genet. 1991 Mar;48(3):439-46.
10
Introduction: new technologies for genetic and newborn screening.引言:基因与新生儿筛查新技术
Yale J Biol Med. 1991 Jan-Feb;64(1):3-7.